보툴리눔독소 주사 Botulinum Toxin Injection
보톡스 주사를 이용한 주름 개선
주요 저널
- Aesthetic plastic surgery 12
- Plastic and reconstructive surgery 12
- Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 10
- Annals of plastic surgery 4
- Aesthetic surgery journal 3
이 분야 핵심 논문
인용·조회·발간연도 종합 점수- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
전체 논문 목록
9,388건 · 최신순-
Streamlined Facial Rejuvenation: A Randomized Split-Face Trial of Premixed Intradermal Botulinum Toxin Type A and Hyaluronic Acid Biorevitalization.
[BACKGROUND] Botulinum toxin type A (BoNT-A) effectively treats dynamic wrinkles but offers limited direct improvement in skin quality. Hyaluronic acid (HA)-based biorevitalization enhances hydration, firmness, and radiance; however, high-q…
-
The Association Between Existing Health Conditions and Adverse Events From Botulinum Toxins: Findings From a UK Cross-sectional Survey in 2024.
[BACKGROUND] There is growing demand for Botulinum toxin (BoNT) injections in the UK. However, there is a scarcity of research in relation to associations between medical conditions and BoNT adverse events. [OBJECTIVES] To investigate cros…
-
Botulinum Toxin Type A in the Treatment of Primary Axillary Hyperhidrosis:A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety in Chinese Patients.
[BACKGROUND] The efficacy and safety of botulinum toxin type A (BoNTA) treatment for primary axillary hyperhidrosis (PAH) have not been explored in the Chinese population. [OBJECTIVES] The objective was to evaluate efficacy and safety of 1…
- Re: 'The effect of botulinum toxin A on dry eye disease and syndromes'.
-
Botulinum toxin for allergic rhinitis: a systematic review and meta-analysis of its therapeutic potential.
[PURPOSE OF REVIEW] Botulinum toxin type A (BTX-A) is emerging as a promising intervention for refractory allergic rhinitis. This study evaluates its effectiveness in treating refractory allergic rhinitis. [RECENT FINDINGS] The primary out…
- Iatrogenic botulism following cosmetic botulinum toxin injection treated with delayed antitoxin therapy.
-
Rac1 promotes exosome secretion from proximal renal tubules to accelerate DKD.
Chronic low-grade sterile inflammation is one hallmark of diabetic kidney disease (DKD). Exosomes secretion from renal cells plays an important role in the transmission of inflammatory substances, which is associated with DKD. Ras-related C…
-
[Retroperitoneal haematoma after injection of botulinum toxin A in the bladder wall].
In this case report, a 77-year-old female attended a department of urology for a flexible cystoscopy in local anaesthesia with injection of botulinum toxin A in the bladder wall. One day later, she presented with suprapubic pain and hypoten…
- Botulinum toxin type A for Lyell's syndrome-associated dyspareunia: A case report.
-
Psychological and motor outcomes of botulinum toxin in hemifacial spasm and blepharospasm.
[PURPOSE] Hemifacial spasm (HFS) and blepharospasm (BSP) impair motor function and psychosocial health. This study assessed anxiety, depression, and self-esteem changes following botulinum toxin A (BoNT-A) treatment. [METHODS] In this pros…
-
Evaluating and reducing environmental waste in oculofacial plastic procedures.
[OBJECTIVE] To identify, develop, and implement interventions that reduce the environmental impact of oculoplastic procedures. [METHODS] Oculoplastic procedures performed in either office-based surgery suites or ambulatory surgery centers …
-
Comparing patient satisfaction and pain control between vibration and topical anesthesia during botulinum toxin A injections: a randomized, double-blind, split-face clinical trial.
This study aimed to evaluate pain levels, patient satisfaction, and preferences for different anesthetic techniques during the cosmetic application of botulinum toxin A in the upper third of the face. A randomized, double-blind, split-face …
-
Manufacture of the first FDA-approved batches of 900 kilodalton crystalline type a botulinum toxin for clinical use: a personal remembrance.
Type A crystalline 900 kDa botulinum toxin (BTX-A) was first approved in December 1989 by the US Food and Drug Agency (FDA) as an orphan drug for treatment of strabismus and blepharospasm associated with dystonia in patients twelve years an…
-
Efficacy and Safety of LetibotulinumtoxinA Injection for Trapezius Hypertrophy: A Prospective, Randomized, Double-Blind Trial.
[BACKGROUND] Trapezius hypertrophy is a significant aesthetic concern among women. Botulinum toxin has emerged as a potential treatment option for this condition. In this study, we conducted a prospective, randomized, double-blind trial to …
-
The effect of botulinum toxin A on dry eye disease and syndromes.
Several innovative treatment modalities for dry eye disease have emerged over the past decade. This systematic review aims to explore botulinum toxin A as a novel treatment modality for dry eye symptoms. PubMed, Cochrane Library, Medline (O…
-
Botulinum Toxin for the Treatment of Motor Tics in Children: A Case Series.
Tic disorders, including Tourette syndrome, are characterized by brief, repetitive, and patterned movements or vocalizations. Botulinum neurotoxin (BoNT) has emerged as a therapeutic option for motor tics, particularly when oral medications…
-
The Use of Anti-CGRP Medications for Management of Intractable Chronic Daily Headaches in the Pediatric Population: Case Series and Literature Review.
BackgroundChronic daily headaches are the cause of significant morbidity in adolescents. Many patients with migraine show minimal response to daily preventive medications and often have significant side effects. Calcitonin gene-related pept…
-
The Significance of Type A Botulinum Toxin Ten-Point Injection Therapy in the Treatment of Chronic Pelvic Pain Caused by Muscle Spasms in Women.
[INTRODUCTION AND HYPOTHESIS] This study aims to evaluate the efficacy, safety, and socioeconomic impact of botulinum toxin type A trigger point injection therapy and ten-point injection therapy for chronic pelvic pain syndrome (CPPS) cause…
-
Clinical Algorithm-Guided Approach to Botulinum Toxin Type A Treatment for Axial Postural Abnormalities in Parkinson's Disease.
[BACKGROUND] Axial postural abnormalities (APAs) are common, disabling complications of Parkinson's disease (PD) with unclear pathophysiology. The presence of hyperactivity in multiple trunk muscles supports the use of botulinum toxin (BTA)…
-
How I Do It: The Transtracheal Approach for Awake Cricopharyngeal Botulinum Toxin Injection.
This transtracheal technique for cricopharyngeal botulinum toxin injection is a safe and effective option for chemodenervation of this muscle in the awake patient. Its advantages include reduced risk of toxin spread to intrinsic laryngeal m…